This flyer provides information on two sponsored, no-charge genetic testing programs available for people who are suspected of having either activated PI3K delta syndrome (APDS), chronic neutropenia, or WHIM syndrome. Find out if your patient qualifies.
- For eligible patients suspected of having APDS, Pharming offers the navigateAPDS program.
- For eligible patients suspected of having chronic neutropenia or WHIM syndrome, X4 offers the Path4Ward program.